Filing Details

Accession Number:
0001179110-19-011243
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-25 17:08:01
Reporting Period:
2019-10-23
Accepted Time:
2019-10-25 17:08:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1203346 Doug G Iiekking 3838 West Parkway Blvd
Salt Lake City UT 84120
Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-23 673 $0.00 2,032 No 4 M Direct
Common Stock Disposition 2019-10-23 286 $77.92 1,746 No 4 F Direct
Common Stock Disposition 2019-10-25 1,746 $75.33 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2019-10-23 673 $0.00 673 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
14,666 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
  2. On October 23rd, 2017, the reporting person was granted 2,691 restricted stock units, vesting at 25% on each 23rd of October thereafter.
  3. Weighted average price $75.325. Price range in multiple transactions was $75.305 to $75.41 inclusively.